Sonus Pharmaceuticals, Inc. Updates Corporate Progress And Reports Second Quarter Financial Results; Quarterly Call To Be Held Today At 1:30 P.M. PDT/4:30 P.M. EDT

BOTHELL, Wash.--(BUSINESS WIRE)--Aug. 9, 2006--Sonus Pharmaceuticals, Inc. (NASDAQ:SNUS) today reported second quarter financial results and updated its progress on 2006 objectives, including the development of TOCOSOL(R) Paclitaxel, the Company's lead oncology drug candidate, and TOCOSOL Camptothecin, Sonus' second oncology product candidate.
MORE ON THIS TOPIC